Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
Completed · Not applicable
Conditions studied: Heart Disease Congenital Complex
In brief
This protocol is designed to offer insight into critical illness related corticosteroid insufficiency and steroid supplementation in neonates undergoing cardiac surgery with cardiopulmonary bypass by administering exogenous steroids in the immediate post-operative period.
Key facts
- Study ID
- NCT01595386
- Run by
- University of Alabama at Birmingham
- People needed
- 40
- Starts
- 2012-04-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2015-11-10
Who can join
Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Neonate (< 28 days old) undergoing correct cardiac surgery, or infants undergoing the following surgery procedures: Norwood, Arterial Switch, Total Anomalous Pulmonary Venous Return Repair, Interrupted Aortic Arch Repair, Truncus Arteriosus Repair
- Successfully weaned off cardiopulmonary bypass after cardiac surgery
You may not qualify if…
- requirement for extracorporeal membrane oxygenation (ECMO) in the operating room
- Known immune deficiency
- Having previously received systemic steroids (except for two routine preoperative doses)
- A current signed Do not resuscitate (DNR) or limitation of care order
- Current enrollment in another interventional clinical study
- Refusal of parental consent
- Previous diagnosis of adrenal insufficiency
- > 28 days old at time of surgery whose repair dose not require CPB
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.